Hydrogenology
Hydrogenology editorial study record

Effect of hydrogen–oxygen inhalation on sleep disorders and abnormal mood: a single-blind, randomized controlled trial

Gao YH et al. · Med Gas Res. 2026;16(2):98–102.

HumanInhaled H₂Published 2026
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Human

Reported design

Single-blind randomized controlled trial

Research topic

Sleep and mood research

Administration classification

Inhaled H₂

Study result signal

Not reported in this record.

Outcome type

Not reported in this record.

Reported in the source

Methods at a glance

Population or model

Adults with sleep disorders

Sample

66 allocated: control n=25; H₂–O₂ n=41. Six Actiwatch datasets were lost; 60 were analyzed for objective sleep state.

Duration

1 hour twice daily for 7 consecutive days

Intervention

Nasal inhalation at 60 mL/min for 1 hour twice daily for 7 days, completed 2 hours before bedtime

Hydrogen form

Brown’s gas / oxyhydrogen — H₂ and O₂ co-delivered, not H₂ alone.

H₂ specification

66.6% H₂ + 33.3% O₂ by volume.

H₂ flow

39.96 mL/min H₂, calculated as 60 mL/min total mixed-gas flow × 66.6% H₂.

O₂ delivered with H₂

19.98 mL/min O₂, calculated as 60 mL/min × 33.3% O₂.

Comparator

Control group without the H₂–O₂ inhalation intervention

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Actiwatch total sleep time, wake time and sleep efficiency; PSQI; depression and anxiety scales

Reported result

Objective total sleep time and wake time and the PSQI and depression scores favored the mixed gas. Between-group sleep efficiency after 7 days and anxiety did not significantly differ.

Results-extraction completeness

Gas composition, flow, methods, results, trial registration, funding and conflicts checked in the open-access full text; independent appraisal remains incomplete.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Single-blind, short trial with unequal groups and six missing Actiwatch datasets. Jinkai Instrument funded the research and was involved in analysis, interpretation and manuscript writing; two authors were company staff.

Applies directly to

Adults with sleep disorders under the reported seven-day protocol.

Preliminary appraisal framework

Not reported in this record.

Preliminary risk-of-bias status

Not reported in this record.

Appraisal rationale

Not reported in this record.

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 40826930 · DOI: 10.4103/mgr.MEDGASRES-D-25-00020

Publisher access

Open-access full text is available through PMC.

Extraction basis

Open-access PMC full text and PubMed bibliographic record.

Record revision

2026-08-10